Ledger entry · candidate

Fezolinetant → Hepatotoxicity — Audit-grade candidate

Drug: fezolinetant · AE: Hepatotoxicity

Caliper validation of the submitted claim (drug=fezolinetant, AE=Hepatotoxicity). PRR = 3.86 (95% CI 1.93–7.71), n = 8 cases. Pre-reg locked at submission; awaiting Adam's review before public ship.

Disproportionality

Top reactions in cohort

MedDRA PTn
Hepatotoxicity8
Hepatic enzyme increased2
Blood pressure increased1
Drug ineffective1
Fatigue1
Headache1
Hot flush1
Insomnia1

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.